Dragon and Tiger List | YKYY (688658) fell by 15.77%, with the top 5 buyers purchasing a total of 116 million yuan, and the top 5 sellers selling a total of 163 million yuan. Reason for being listed: The closing price drop of the top five securities reached 15% with price fluctuation limits
I'm LongbridgeAI, I can summarize articles.On June 5th, YKYY (688658) appeared on the stock trading list due to a closing price drop of 15%. The stock price fell by 15.77% that day, closing at 13.73 yuan. The trading list shows that the total buying by the top five was 116 million yuan, while the total selling by the top five was 163 million yuan, resulting in a net sell of 47.5576 million yuan. The Shanghai Stock Connect, institutions, and several brokerage seats participated in the trading. The company's recent performance is under pressure, with a projected revenue decline of 35.30% in 2025 and a net loss of 262 million yuan
According to Tongbi Finance, on June 5th, YKYY (688658) appeared on the stock market's leaderboard. The reason for its listing: this stock was among the top five securities with a daily closing price drop limit reaching 15%. The buying amount on the leaderboard was 116 million yuan, the selling amount was 163 million yuan, and the net buying amount was -47.576 million yuan.
The top five buying amounts totaled 116 million yuan. Among them, the first buying position was for the Shanghai Stock Connect, with a purchase of 59.621 million yuan; the second buying position was for JP Morgan Securities (China) Co., Ltd. Shanghai Yincheng Middle Road Securities Business Department, with a purchase of 20.4061 million yuan; the third buying position was for Guotai Junan Securities Co., Ltd. headquarters, with a purchase of 14.716 million yuan; the fourth buying position was for CITIC Securities Co., Ltd. Shanghai Branch, with a purchase of 12.1196 million yuan; the fifth buying position was for Goldman Sachs (China) Securities Co., Ltd. Shanghai Pudong New Area Century Avenue Securities Business Department, with a purchase of 9.0674 million yuan.
The top five selling amounts totaled 163 million yuan. Among them, the first selling position was for institutional use, with a sale of 63.2278 million yuan; the second selling position was for the Shanghai Stock Connect, with a sale of 53.5748 million yuan; the third selling position was for China Galaxy Securities Co., Ltd. Beijing Anzhenmen Securities Business Department, with a sale of 16.1603 million yuan; the fourth selling position was for Goldman Sachs (China) Securities Co., Ltd. Shanghai Pudong New Area Century Avenue Securities Business Department, with a sale of 15.7101 million yuan; the fifth selling position was for CITIC Securities Co., Ltd. Beijing Branch, with a sale of 14.8149 million yuan.
As of the close on June 5th, YKYY (688658) fell by 15.77%, with a closing price of 13.73 yuan, a circulating market value of 6.179 billion yuan, and a turnover rate of 8.54%.
Tongbi Finance Tip:
YKYY (688658.SH) is projected to have an operating revenue of 2.446 billion yuan in 2025, with a revenue growth rate of -35.30%, and a net profit attributable to the parent company of -262 million yuan, with a net profit growth rate of -312.09%, and a return on equity of -7.61%.
In the first quarter of 2026, the company's operating revenue was 555.6 million yuan, with a revenue growth rate of -3.70%, and a net profit attributable to the parent company of -33 million yuan, with a net profit growth rate of 32.81%.
Currently, the company belongs to the healthcare industry, with main product types including antibiotic anti-infection preparations, nervous system preparations, digestive system preparations, and raw materials. The 2025 report shows the main composition as cardiovascular: 43.42%; anti-infection: 24.1%; raw materials: 8.67%; digestive system: 8.58%; others: 7.54%; hypoglycemic: 7.35%; other businesses: 0.26%; technical services: 0.09%.